Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Morgan, RJ; Braly, P; Leong, L; Shibata, S; Margolin, K; Somlo, G; McNamara, M; Longmate, J; Schinke, S; Raschko, J; Nagasawa, S; Kogut, N; Najera, L; Johnson, D; Doroshow, JH
   Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracilin previously treated patients with advanced ovarian cancer: Long-term follow-up
   GYNECOLOGIC ONCOLOGY
   
   R.J. Morgan et al., "Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracilin previously treated patients with advanced ovarian cancer: Long-term follow-up", GYNECOL ONC, 77(3), 2000, pp. 433-438
2. Morgan, RJ; Braly, P; Cecchi, G; Leong, L; Shibata, S; Margolin, K; Somlo, G; McNamara, M; Longmate, J; Schinke, S; Raschko, J; Nagasawa, S; Kogut, N; Parker, P; Stein, A; Cho, J; Smith, E; Coluzzi, P; Najera, L; Johnson, D; Womack, E; Doroshow, JH
   Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up
   GYNECOLOGIC ONCOLOGY
   
   R.J. Morgan et al., "Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up", GYNECOL ONC, 75(3), 1999, pp. 419-426
3. TABERNERO D; SANMIGUEL JF; GARCIASANZ R; NAJERA L; GARCIAISIDORO M; PEREZSIMON JA; GONZALEZ M; WIEGANT J; RAAP AK; ORFAO A
   INCIDENCE OF CHROMOSOME NUMERICAL CHANGES IN MULTIPLE-MYELOMA - FLUORESCENCE IN-SITU HYBRIDIZATION ANALYSIS USING 15 CHROMOSOME-SPECIFIC PROBES
   The American journal of pathology
   
   D. Tabernero et al., "INCIDENCE OF CHROMOSOME NUMERICAL CHANGES IN MULTIPLE-MYELOMA - FLUORESCENCE IN-SITU HYBRIDIZATION ANALYSIS USING 15 CHROMOSOME-SPECIFIC PROBES", The American journal of pathology, 149(1), 1996, pp. 153-161